Journal
CANCER REPORTS
Volume 5, Issue 5, Pages -Publisher
WILEY
DOI: 10.1002/cnr2.1496
Keywords
case report; FLT3; hemophagocytic lymphohistiocytosis; KMT2A; NOTCH2; primary splenic histiocytic sarcoma
Categories
Ask authors/readers for more resources
Primary splenic histiocytic sarcoma is an extremely rare tumor of the hematopoietic system, with this case being the first reported with mutations in FLT3, NOTCH2, and KMT2A, along with associated hemophagocytic lymphohistiocytosis.
Background Histiocytic sarcoma is a very rare monocyte/macrophage-derived hematopoietic system tumor with a poor prognosis whose diagnosis is pathologically challenging due to its extreme rarity and histological overlap with various mimicking entities in which histiocytes also predominate. Case We report the case of a 33-year-old male patient with hemophagocytic lymphohistiocytosis, purpuric syndrome, and significant splenomegaly. The patient underwent splenectomy; subsequent macroscopic examination revealed a spleen weighing 2065 grams with hyperemic red pulp and multiple infarcts at the periphery. The histological and immunohistochemical study established a diagnosis of primary splenic histiocytic sarcoma with frequent hemophagocytosis. Next-generation sequencing demonstrated mutations in FLT3, NOTCH2, and KMT2A, microsatellite stability, and a tumor mutational burden of 2 mut/Mb. The patient's condition deteriorated clinically from the appearance of the first symptoms and he died 6 months later from multi-organ failure. Conclusion Primary splenic histiocytic sarcoma is one of the rarest tumors of the hematopoietic system. We report the first case with mutations in FLT3, NOTCH2, and KMT2A, and associated hemophagocytic lymphohistiocytosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available